Page 47 - Pharma

Dr Reddy's launches dementia drug in US

Memantine hydrochloride tablet is a generic version of Merz Pharma's Namenda tablets, which recorded US sales of about $ 1.4 billion in last twelve months ending in May 2015

Samina Vaziralli joins Cipla board

She has been with the company since 2011 and was responsible for successfully incubating and shaping Cipla's consumer healthcare business as part of Cipla New Ventures

Cipla plans to divest consumer healthcare business

The OTC division recorded Rs 34.88 crore turnover or approximately 0.3 percent of the total consolidated income of Cipla for 2014-15

Kellton Tech wins Rs 27.5 crore healthcare project in UP

This three year project is slated to be the largest enterprise mobile application rollout in the health and e-governance sector of India

Caplin Point receives EU GMP nod for sterile injectable facility in Chennai

With this, the company is aiming to tap the global injectable market, which is projected to grow to $ 70 billion by 2020

Healthcare cloud computing market to reach $9.48 bn by 2020

The security of patient data on cloud is a crucial issue that is likely to restrain the growth of this market, says Marketsandmarkets

BASF, Poietis team up to develop 3D bioprinting technology for skin care applications

Two companies will combine their expertise to enhance bioprinted 3D tissue models to support the development and testing of cosmetic bioactives for skin care applications

Bliss GVS Pharma receives $35 mn contract in Kenya

The contract was awarded by Teachers Services Commission to Bliss GVS Healthcare, in association with Aon Kenya Insurances, for providing medical healthcare services in Kenya

Government targets 95% immunisation cover by end of 2016

Over 60 percent of the global vaccine demand is met by Indian producers

Sartorius Stedim Biotech acquires Cellca

Cellca GmbH offers cell line and process development services for large-scale protein production of biologics in mammalian (CHO) cells

Medical contrast media market to touch $ 5.17 bn by 2020

The Asia-Pacific market is expected to grow at the highest CAGR during the 2015-2020, says a MarketsandMarkets report

Novo Nordisk to pull out insulin Tresiba from Germany

The decision to pull out was taken after a negative outcome of price negotiations with the GKV-Spitzenverband, the German national association of statutory health insurance funds

Lupin enters Russian pharma market with acquisition of Biocom

This is Lupin's second major acquisition in BRICS countries this year. It had acquired Brazil's Medquimica in May

Air Liquide acquires Irish firm Baywater Healthcare

The acquisition will help Air Liquide to expand its home healthcare business in Europe

Centre launches Pharma Price Data Bank

Data bank is an integrated pharmaceutical database management system that will be used by pharma companies to make online submission of mandatory information/data

USPTO grants patent to Take Solutions' clinical data solution

The solution leverages Take Solutions' clinical accelerators to reduce the time taken to standardise trial data by over 50 percent, claims the company

US pharmaceutical chemicals demand to reach $ 47 bn in 2019

Active ingredients of CNS agents will remain the largest therapeutic group served by pharmaceutical chemicals based on value, according to a Freedonia Group report

Suven Life receives three patents for CNS drug

The company has received product patents in Israel, Japan and South Africa

Marksans Pharma acquires US-based Time-Cap

With its acquisition of Time-Cap, which has US FDA-approved facility in New York, Marksans is strategically increasing its presence in the US market

Thermo Fisher acquires Johnson Matthey's Alfa Aesar for Pound 256 mn

Johnson Matthey's research chemicals business, which operates globally under the Alfa Aesar brand, is a supplier of over 45,000 speciality chemicals